Skip to main content
News Hagelueken 08.2022 1
PD Dr. Gregor Hagelueken (left) and Dr. Martin Peter (right)
© Johann Saba / UKB

News categories: Publication

Cross-validation of distance measurements in proteins

Large scale analysis of PELDOR/DEER and smFRET as complementary tools in structural biology

In order to investigate intermolecular distances, conformational changes or structural heterogeneity of biological molecules, two different methods are widely used: Pulsed electron-electron double resonance spectroscopy (PELDOR/DEER) and single-molecule Förster resonance energy transfer spectroscopy (smFRET). Scientists of the excellence cluster ImmunoSensation2 at the University of Bonn and of the Ludwig-Maximilians-Universität (LMU) Munich have now compared the accuracy of the two methods. The study has now been published in the journal Nature Communications.

The researchers from PD Dr. Gregor Hagelueken's group at the Institute of Structural Biology of the University Hospital Bonn (UKB) used four different proteins as model structures to be analyzed: Three different substrate binding proteins (SBPs), and an actin-binging virulence factor, all four exhibiting large conformational changes upon ligand binding. PELDOR spectroscopy was used to determine inter-probe distances at the nanometre scale and detect conformational changes of the macromolecules in their (frozen) solution state. Identical experiments were carried out at the research group of Prof. Dr. Thorben Cordes at LMU Munich, using smFRET spectroscopy.

"Although both methods are used very frequently, no one has yet systematically investigated whether the results are really comparable," says Hagelueken. Although it turned out that the results were comparable in most cases, the researchers encountered inconsistencies in two cases. Bonn post-doctoral researcher Martin Peter says, "We then thoroughly investigated what caused the differences and found what we were looking for. In one case, it turned out that the dye molecules stuck to the protein and thus falsified the measurement." In the second case, the addition of a type of antifreeze, which was necessary because of the low measurement temperature of below -220 degrees Celsius, led to unexpected deviations. "We were able to show that despite the high accuracy of the methods, re-measuring with another nano ruler is always a good idea," Hagelueken says.


Publication

Martin F. Peter, Christian Gebhardt, Rebecca Mächtel, Gabriel G. Moya Muñoz Janin Glaenzer, Alessandra Narducci, Gavin H. Thomas, Thorben Cordes, Gregor Hagelueken: Cross-validation of distance measurements in proteins by PELDOR/DEER and single-molecule FRET; Nature Communications; https://doi.org/10.1038/s41467-022-31945-6



Contact

PD Dr. Gregor Hagelueken

Institute for Structural Biology

University Hospital Bonn

Phone: +49 228 287-51200

Email: hagelueken(at)uni-bonn.de

Related news

Prof. Christian Strassburg, Direktor der Klinik für Allgemeine Innere Medizin am UKB, mahnt: „Die Abnehmpille ist nicht einfach nur irgendein Spaßfaktor, um jetzt ein bisschen abzunehmen!“

News categories: Publication

Weight-Loss Pill Instead of Injection: Finally, an Easy Way to Lose Weight?

As of September 1, semaglutide will be available in Germany for the treatment of overweight and obesity in tablet form for the first time. The therapy, previously known primarily as a “weight-loss injection,” can now also be taken orally. The market launch is likely to attract considerable interest – but anyone considering treatment should be aware of one thing first: the tablet is not a way to lose a few kilos, but a prescription medication for the treatment of a chronic disease.
View entry
Prof. Matthias Geyer, - together with Prof. Robert P. Fisher from New York, provides an overview of the current state of research on the transcriptional regulation of cyclin-dependent kinases (CDKs) and the prospects for cancer treatment.

News categories: Publication

A Ray of Hope in the Fight Against Cancer

Cancer is the second leading cause of death in Germany. In the search for new therapeutic approaches that target the uncontrolled growth of tumor cells, a class of enzymes known as cyclin-dependent kinases (CDKs) has come into focus. This is because this family of enzymes plays a fundamental role in gene expression and cell division. An overview of the current state of research on the transcriptional regulation of CDKs and the prospects for cancer treatment was compiled by Prof. Matthias Geyer of the UKB in collaboration with Prof. Robert P. Fisher and has now been published.
View entry
(from left) Julia Nicke and Dr. Mona Malek Mohammadi have identified a previously unknown signaling pathway in the immune system that helps newborn heart cells survive and regenerate after injury.

News categories: Publication

Central Hub for Heart Repair Discovered Bonn study: Heart muscle interaction enables cardiac regeneration in the neonatal heart

Researchers at the University Hospital of Bonn (UKB) and the University of Bonn have identified a previously unknown signaling pathway in the immune system that helps newborn heart cells survive and regenerate after injury. The findings could open new avenues for future therapies aimed at repairing damaged adult hearts after heart attacks or chronic cardiovascular disease. The study has now been published in the journal Cell Communication and Signaling (Springer Nature).
View entry

Back to the news overview